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ABSTRACT 
 
Radiotherapy is the most common cancer treatment modality applying ionizing radiation. In majority of the cases, 
RT necessarily affects on normal tissues around the tumor. Silymarin is one of the most important chemical 
ingredients of the milk thistle. Silymarin composed of six flavonolignans that Silibinin, with 40-50%, is the most one.  
In view of the innumerable beneficial effects of silymarin in the management of ROS-mediated diseases, it was felt 
that silymarin could act as a promising radiation countermeasure agent. In this review paper we introduce 
Silymarin as herbal radioprotectors.  
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INTRODUCTION 
 
Radiation biology  
Radiotherapy (RT) is the most common cancer treatment modality applying ionizing radiation. In majority of the 
cases, RT necessarily affects on normal tissues around the tumor [1]. Exposure of the tissues result in oxidative 
stress due to water radiolysis and producing ROS (reactive oxygen species) (e.g. OH•, H•, H2O2, and H3O+), 
consuming cellular antioxidant supply and react with DNA, RNA, proteins, cell membrane's lipids, etc [2]. that 
induce cell dysfunction resulting cell death. Radiation damage to the biological systems is happening via two 
processes: a) direct effect, in which radiation energy is absorbed through target molecules of DNA and or RNA, 
resulting in molecular injury [3]. b) Indirect effect, in which the molecule is chemically altered through reactions 
with free radicals (FṘ) and ROS produced primarily from the radiolysis of water. The final effect of direct or 
indirect radiation damage is disturbance of molecular structure and function, leading to change cell metabolism. 
Lipid per oxidation happens after irradiation or FṘ assault. This introduces to manufacture of short chain fatty acid 
derivatives, lipid-lipid cross-link and protein-protein as well as lipid-protein cross-link, oxidation of accessible 
amino acids, protein denaturation, and scission of disulphide bonds in proteins. Consequently, these alterations can 
be changed membrane fluidity and permeability, which could trigger the release of potent physiological mediators 
[4]. Activity of enzymes related with these membranes may be changed by the disturbance of lipid 
microenvironment and protein structure. In summary, RT injures normal cells around the tumor and patient may 
experiences certain symptoms during RT course or later on [5].     
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Due to the immense applications of unplanned radiation exposure as well as planned RT, radiation protection is an 
important issue. Scientists have developed treatment strategies in order to reduce the side effects of RT and facilitate 
the healing of radiation damages in normal tissues [6]. Studies in the improvement of radioprotectors (RPs) have 
focused on screening various biological and chemical compounds. During the last decades, several synthetic and 
natural agents have been investigated for their potential as a RP. For instance, the radioprotective effects of 
antioxidants, cytoprotective factors, immune-modulators, vitamins and DNA binding molecules have been evaluated 
in-vitro and in-vivo worldwide [7]. However, the plan was imperiled when synthetic compounds was administrated 
in RT to reduce the unwanted radiation side effects. Contradictory, available clinical results show that it is difficult 
to make a clear decision to deny or accept application of synthetic RPs during RT in a conclusive method. While, 
clinical trials in which the effects of antioxidant vitamins, as an adjacent modality with RT, against the acute 
opposed side effects were evaluated demonstrate that application of high doses antioxidants, could improve 
treatment effectively; up to now there is no ideal synthetic RP available that not only does not have cumulative or 
irreversible toxicity, but also can be easily administered and provides efficient long-term protection against 
radiation. In contrast, researchers reported various herbal products for FṘ-mediated conditions in human's disease 
and disorders. Studies to access efficient with low toxicity RPs leads to growing interest on natural compounds. 
Scientists extracted several effective RPs from the plants; however, improvement of a safe, effective, and nontoxic 
RP for clinical application is still under investigation. Thus, several procedures have been developed to prevent 
patients by interfering in the improvement of ionizing radiation injuries. One of the most famous herbal RP is 
Silybum Marianum, generally known as Milk Thistle. Silymarin is one of the most important chemical ingredients 
of the milk thistle [7]. Silymarin composed of six flavonolignans that Silibinin, with 40-50%, is the most one.  In 
this review paper we introduce Silymarin as herbal RP [8].  
 
Failures of the current RPs and Silymarin characteristics as an herbal RP 
The early progression of RPs led to the finding of synthetic thiol ingredients; although they had certain undesirable 
side effects [9]. Hence, researchers planned studies for the novel RPs that not only could be more efficient with less 
toxicity, but also they could be more acceptable for prescription. In the last decade, a number of synthetic 
compounds, chelating agents and natural antioxidants have been tested for their capabilities to protect RT-induction 
injuries. The main focus was, of course, on natural and synthetic agents, such as organometallic compounds and 
biological response adjusters. Immunomodulators are non-cytokine agents, suggesting as an option to motivate 
hematopoietic stem cells [10]. These could invigorate growth, differentiation and proliferation of hematopoietic' 
stem cells, hence preventing and repairing radiation induced injuries. In our diet there are different natural 
ingredients that are including antioxidants, e.g. enzyme, minerals materials and vitamins [11]. Decreasing of 
oxidation injury by natural antioxidants prepares a sort of defense against radiation damage. Furthermore, 
researchers have been improved more synthetic super oxide dismutase (SOD) mimetic substances, with a metal ion, 
such as Cu, Fe, Mn and Zn. Most of these drugs had a variety of radiation protection in patients treated by RT. Up to 
now WR-2721 is the best chemical RP; although it is not prescribe in RT of all cancer patients due to its harmful 
side effects and extremely high price. Thus, the intention in the RP improvement tilted to RPs in which the 
fundamental function is FṘ scavenging. The efficiency of RP is stated as dose reduction factor (DRF) that is 
calculated by plotting the survival fraction 30 days after RT versus the RT dose [12].    
 
In the recent years scientists have worked the radioprotective investigation towards the phytochemicals and plant 
extracts. Arora et. al. explained status of the present and future prospective of herbal RPs focusing on the potential 
of natural compounds based RP drug discovery. Man has been used plants for curing diseases from very long time 
ago and it continue till now. Nowadays, roughly 70% of the world’s healthcare is based on application of plants and 
herbal products. Researches reveal that some of the plants and their extracts have been prosperously used to treat 
FṘ-mediated sicknesses and disorders for instance cancer, Parkinson, Alzheimer disease, atherosclerosis, arthritis 
rheumatoid, aging, and inflammatory diseases [13, 14]. Thus, it would be reasonable to expect that plants may 
contain several ingredients that can protect versus ROS-mediated injuries. Many of herbal medicinal plants 
investigated for their radioprotective efficiency and the results have proven their RP effects [15]. The 
radioprotective efficacy of the herbal extracts consist of a plenty of components including cell proliferation 
stimulators, anti-inflammatory and antimicrobial agents, immunostimulants, as well as antioxidants, some of which 
may perform in isolation and in combination with other compounds from the same one. Majority of the researches 
applying herbal products have focused on investigation of radioprotective efficiency of entire extracts or polyherbal 
formulas, and in certain cases, fractionated extracts and isolated components. Several researches have been reported 
to be radioprotective in different model systems. Some of the products including antioxidant have the capability to 
moderate harmful effects of ionizing radiation in biological systems and bio-molecules that include cruciferous 
Daryoush Fatehi et al Der Pharmacia Lettre, 2016, 8 (9):146-150 
______________________________________________________________________________ 
148 
Scholar Research Library 
vegetables (e.g. broccoli and cabbage), Mentha  arvensis  Linn (mint), Podophyllum  hexandrum Linn. (Himalayan 
May apple), Spirulina platensis, and green tea (polyphenols), bixin (carotenoid), Gingko biloba Linn. extract 
(flavone glycosides and terpene lactones), and milk thistle (Silymarin) [16]. Many of the works utilizing 
phytochemicals have concentrated on assessment of radioprotective efficiency of total extracts or polyherbal 
formulas and in a number of cases a part of the extracts and isolated ingredients, for their capability to protect 
against radiation-induced chromosomal aberrations and micronuclei formation. Although many plants potentially 
demonstrate having different biological actions that could be related to the appeasement of ionizing radiation-
induced injuries in mammalian systems; only a few of them have been evaluated systematically. Some of the herbal 
products such as vitamins, flavonoids, carotenes, and polyphenols, are known to illustrate antioxidant characteristics 
[16]. Silymarin for its unique properties, e.g. no toxicity, bioactive flavonoid, approved herbal hepatoprotectant; 
uses widely around the world, as a dietary antioxidant, in order to protect against many of disorders and diseases as 
well as their treatment. 
 
Many in vitro and in vivo models have been illustrated anti-inflammatory, antioxidant, and anti-carcinogenic 
characteristics of Silymarin versus the inflammatory responses, oxidative stress, and chemical carcinogen-induced 
tumor promotion. Furthermore, studies have shown that Silymarin increases aspartate glutamyltranspeptidase (GGT) 
and -aminotransferase (ALT) and of the plasma. Additionally, Silymarin is used as a topical ointment for treatment 
of breast cancer worldwide. Moreover, Silymarin is known to adjust proinflammatory pathways via down regulation 
of cyclooxygenase-2 (COX-2) and 5-lipooxygenase (LOX); therfore, protection of hepatic cytochrome P450 
detoxification system engaging hepatic cytochrome P450 enzyme activities [17]. Silymarin is able act as a RP for 
liver by maintaining membrane permeability and protecting hepatic glutathione exhausting. Moreover, Silymarin not 
only acts as a hepatoprotective factor; but also it has protective effects versus different drugs of nephrotoxic nature. 
Studies demonstrate that Silibinin protects hepatocytes, since it can block the hepatotoxin receptors available on the 
membrane of the hepatocyte; thus, it protects cells against death and apoptosis. Additionally, studies show that 
Silynmarin prevents from hepatotoxins by decreasing the quantity of oxidized Glutathione (GSH) in the liver and 
intestine; motivate the ribosomal RNA polymerase and protein synthesis resulting in intensified regeneration of 
hepatocytes [18]. In mouse it has been proved that Silymarin could prevent liver versus fumonisin B1 –induced 
injury and sepsis-induced acute lung and brain damage. The strong hepatoprotective influence of Silymarin versus 
cytotoxicity and apoptosis happened by Ochratoxin A (OTA), has been illustrated in cultured primary rat 
hepatocytes [19]. The hepatoprotective effects of OTA, in Aflatoxin B1, have also been presented in case of albino 
male Wistar rats. Studies on broiler chickens reveal that Silymarin derived -phospholipid complex is engaged in 
decreasing toxicity of aflatoxin B1 (AFB1). Furthermore, potential impacts of Silymarin as used in adjacent by 
vitamin E versus (OTA)-induced immunotoxic outcomes in White Leghorn cockerels have also been illustrated[20]. 
Moreover, prevention impacts of Silymarin on L-arginine-induced genotoxicity demonstrated in lymphocyte culture 
in-vitro. Silymarin includes phytochemicals components such as lignans and flavonoids. Studies elucidated that 
these compounds individually have substantial influence opposite different pathological symptoms as well as having 
radioprotective characteristics. Silymarin can extend the DNA repairmen time, as it can elevates G2/M phase arrest. 
Additionally Silymarin down regulates the ethanol-induced oxidative damage and increases the activities of 
Interleukin-10 (IL10), tumor necrosis factor α, γ -interferon and vascular endothelial growth factor [21]. Silymarin is 
also known to downregulate some anti-apoptotic gene manufactures engaged with reproduction of tumor cells. It has 
been revealed to possess chemo-preventive characters and protects prostate and skin cancer [22]. 
 
Lignans and flavonoids exist in Silymarin particularly have been elucidated having anti-radiation properties. 
Ordinarily, certain chemical components have been evaluated for RP capability. However, the individual 
applicability of most of the synthetic agents remained limited, because of their toxicity at an optimum dose. In order 
to decrease toxicity of a synthetic component, one needs to investigate the ingredients; which could be more 
efficient and less toxic [23]. An extensive field of research interest advances such kind of constituents lies in the 
application of natural ingredients. Application of natural agents for enhancing one’s health has increased in the 
modern age. Thus, this would be quite logic that the selection of alternative RPs falls on plants and plant extracts. 
However, application of these extracts or plants, as RPs needs investigation in a scientific manner. When this is 
done, a natural RP could be more efficient than a chemosynthetic agent. In summary, an effective and suitable RP 
must physiologically has the following characters: 1) FṘ scavenger; 2) Radiooxidative damage; 3) Facilitate DNA 
and cellular repair; 4) Immunomodulation; and 5) Facilitate repopulation of damaged and affected organs [24]. 
 
Furthermore, "the natural RPs perform their protective effect through certain processes as shown in the following 
section: 1) FṘs scavenging (antioxidant process); 2) Up regulate mRNAs of antioxidant enzymes such as catalase, 
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glutathione transferase, glutathione peroxidase, superoxide dismutase; 3) Promoting the recovery of hematopoietic 
and immune functions; 4) Compaction of DNA; 5) Triggering the DNA repair enzymes; 6) Detoxifying the radiation 
induced reactive species; 7) Delay of cellular division and inducing hypoxia in the tissues; 8) Reduction in lipid 
peroxidation and elevation in non-protein sulphhydryl groups; and 9) Inhibit activation of protein kinase, nitrogen 
activated protein kinase, cytochrome P-450, nitric oxide" [25]. 
 
"In order to take in account herbal drug as RPs, one must consider the following items: 
1. The exact composition  
2. Mechanism of action of each component 
3. Possibility of synergistic action between different components 
4. Exploration regarding mechanism of action as RPs 
5. Elimination of the toxic components from the extract 
6. Pharmacokinetics of the different components in the body organs 
7. Some physico-chemical parameters like membrane permeability, interaction possibilities with cellular and 
nucleolar membranes, diffusion coefficient of the components, interaction possibilities with body fluids, 
biodistribution etc [26]. 
 
Nowadays, human exposure to ionizing radiation is increasing due to the improvement in science and technology. 
The development of radioprotective drugs is important to prevent patients from the side effects of radiotherapy, as 
well as the public from unwanted irradiation [27]. 
 
CONCLUSION 
 
Nuclear and radiological accidents can result in moderate to severe radiation damages and massive mortality. The 
harmful effect of γ-radiation on biological systems is well known. Plants are inherently gifted with the capability to 
resistant against the deleterious radiation from the sun. Intensive exposure to ionization radiation by accidental, 
occupational or therapeutical purpose causes cellular damage mainly by formation of excessive ROS or by FṘs. 
Recently, interest of radiation protection has tilted to evaluate the radioprotective potential of plants and herbs in the 
hope that one day it will be possible to find a suitable pharmacological agent(s) that could protect humans against 
the harmful effects of ionizing radiation. Thus, it can be said that plants are supplied with certain prevention 
components to protect themselves from the radiation stimulated injuries and oxidative stress. The use of 
phytochemicals in radioprotection has received much attention in the last decade owing to certain discoveries with 
special properties as antioxidants. Generally, they are popular because the phytochemicals have less toxicity in 
human; as many of these are used alternatively in Asian countries for centuries. Furthermore, preclinical studies 
showed that they are available more easily, inexpensive and good radioprotection. The radioprotective activity of 
phytochemicals may be mediated via certain mechanisms such as FṘ scavenging, improvement in the antioxidant 
status, and anti lipidperoxidation potential, conferred due to the presence of variety of phenolic hydroxyl groups 
attached to the ring structure. Polyphenols especially flavonoid glycosides, isoflavones and their derivatives 
(quercetin, catechin, myricetin, luteolin, orientin, naringin, apigenin, etc.) have ketone groups conjugated to 
aromatic rings which are activated by electron donor substituents, thus inhibiting energy transfer, suppressing 
oxidative stress and stabilizing redox processes in cells. The polyphenols may upregulate mRNAs of antioxidant 
enzymes such as catalase, glutathione transferase, glutathione peroxidase, and superoxide dismutase, thus 
counteracting the oxidative stress induced by ionizing radiations. Up-regulation of DNA repair genes and inhibition 
of genes such as protein kinase C (PKC), mitogen activated protein kinase (MAPK), cytochrome P-450, and nitric 
oxide may also protect against radiation-induced DNA damage. Herbal extracts efficiently restore the disturbed 
equilibrium during radiation injury, in a collective and holistic manner owing to their varied phytochemical 
spectrum. Finally, studies may be designed to bring out lead radioprotector molecules in the market with patient 
acceptable profile. The multifarious activities exhibited by Silymarin, including hepatoprotective, gastroprotective, 
antioxidative, renoprotective and anti-inflammatory, and its efficacy in recent clinical trials for treatment of a large 
number of diseases goes on to prove its safety and efficacy in humans. In view of the innumerable beneficial effects 
of silymarin in the management of ROS-mediated diseases, it was felt that silymarin could act as a promising 
radiation countermeasure agent [28]. 
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